Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
JCO Oncology Practice
|
May 13, 2025
Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates
Eleonora Nicolò, Caterina Gianni, Paolo Tarantino
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer
|
November 13, 2024
Adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: one fits all?
Caterina Gianni, Eleonora Nicolò, Massimo Cristofanilli
Expert Opinion on Therapeutic Targets
|
November 12, 2021
Novel immune targets for the treatment of triple-negative breast cancer
Chiara Corti, Eleonora Nicolò, Giuseppe Curigliano
Hematology/Oncology Clinics of North America
|
November 26, 2022
Biology and Treatment of HER2-Low Breast Cancer
Eleonora Nicolò, Paolo Tarantino, Giuseppe Curigliano
European Journal of Cancer (Oxford, England : 1990)
|
November 12, 2022
Response to letter entitled: Re: "Evolution of low HER2 expression between early and advanced-stage breast cancer"
Paolo Tarantino, Eleonora Nicolò, Giuseppe Curigliano
Current Opinion in Oncology
|
July 14, 2020
Antibody-drug conjugates in breast cancer: the chemotherapy of the future?
Eleonora Nicolò, Paola Zagami, Giuseppe Curigliano
Expert Opinion on Biological Therapy
|
June 29, 2019
Biosimilars for breast cancer
Bruna Migliavacca Zucchetti, Eleonora Nicolò, Giuseppe Curigliano
Current Opinion in Oncology
|
August 25, 2023
HER2-positive breast cancer: cotargeting to overcome treatment resistance
Paola Zagami, Luca Boscolo Bielo, Eleonora Nicolò, et al.
Therapeutic Advances in Medical Oncology
|
February 27, 2023
The HER2-low revolution in breast oncology: steps forward and emerging challenges
Eleonora Nicolò, Luca Boscolo Bielo, Giuseppe Curigliano, et al.
Cancers
|
July 2, 2021
Antibody-Drug Conjugates for the Treatment of Breast Cancer
Chiara Corti, Federica Giugliano, Eleonora Nicolò, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
JCO Oncology Practice
|
May 13, 2025
Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates
Eleonora Nicolò, Caterina Gianni, Paolo Tarantino
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer
|
November 13, 2024
Adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: one fits all?
Caterina Gianni, Eleonora Nicolò, Massimo Cristofanilli
Expert Opinion on Therapeutic Targets
|
November 12, 2021
Novel immune targets for the treatment of triple-negative breast cancer
Chiara Corti, Eleonora Nicolò, Giuseppe Curigliano
Hematology/Oncology Clinics of North America
|
November 26, 2022
Biology and Treatment of HER2-Low Breast Cancer
Eleonora Nicolò, Paolo Tarantino, Giuseppe Curigliano
European Journal of Cancer (Oxford, England : 1990)
|
November 12, 2022
Response to letter entitled: Re: "Evolution of low HER2 expression between early and advanced-stage breast cancer"
Paolo Tarantino, Eleonora Nicolò, Giuseppe Curigliano
Current Opinion in Oncology
|
July 14, 2020
Antibody-drug conjugates in breast cancer: the chemotherapy of the future?
Eleonora Nicolò, Paola Zagami, Giuseppe Curigliano
Expert Opinion on Biological Therapy
|
June 29, 2019
Biosimilars for breast cancer
Bruna Migliavacca Zucchetti, Eleonora Nicolò, Giuseppe Curigliano
Current Opinion in Oncology
|
August 25, 2023
HER2-positive breast cancer: cotargeting to overcome treatment resistance
Paola Zagami, Luca Boscolo Bielo, Eleonora Nicolò, et al.
Therapeutic Advances in Medical Oncology
|
February 27, 2023
The HER2-low revolution in breast oncology: steps forward and emerging challenges
Eleonora Nicolò, Luca Boscolo Bielo, Giuseppe Curigliano, et al.
Cancers
|
July 2, 2021
Antibody-Drug Conjugates for the Treatment of Breast Cancer
Chiara Corti, Federica Giugliano, Eleonora Nicolò, et al.
Page
of 5